Publication details

Characterization of in vitro lytic activity of bacteriophage preparation STAFAL against Staphylococcus aureus

Authors

PANTŮČEK Roman DVOŘÁČKOVÁ Milada BENEŠÍK Martin DOŠKAŘ Jiří MAŠLAŇOVÁ Ivana RŮŽIČKOVÁ Vladislava RŮŽIČKA Filip MOŠA Marek

Year of publication 2013
Type Conference abstract
MU Faculty or unit

Faculty of Science

Citation
Description Staphylococcus aureus is one of the most common gram-positive opportunistic pathogens in humans causing from minor skin to severe systemic infections. The newly acquired genes responsible for virulence and resistance to antibiotics are rapidly disseminated in the staphylococcal population and multiple-resistant S. aureus strains represent a significant medical problem. Bacteriophages with a broad host range are suitable for fighting these pathogenic bacteria as an alternative to antibiotic therapy. In this work we summarize the results of susceptibility testing of S. aureus strains to bacteriophage preparation STAFAL in a routine clinical microbiology laboratory. STAFAL is an antistaphylococcal phage lysate for topical application produced under GMP by IMUNA s.r.o. in the Czech Republic, containing highly effective virulent phage particles with a strong and rapid lytic and polyvalent effect. A set of 400 S. aureus strains collected from 10 health-care facilities in Brno (Czech Republic) during 2011 -2013 , including isolates from outpatients' and inpatients' departments was tested in this work.
Related projects: